RxDoctor Payments Data

Amanda Lariscey, PA

Physician Assistant · Vidalia, GANPI 1780164590

Payments from drug & device makers

$1,688in general payments, 2019–2025

Across 92 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$415
  • Novo Nordisk$219
  • Lilly USA, LLC$148
  • Insmed, Inc.$140
  • AstraZeneca$102
  • Pfizer$73
  • plus $590 from 17 others

What the payments were for

  • Food & beverage$1,58894%
  • Education$1006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,688 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$37,229
Medicare patients
132
Services billed
1,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide133$155,856
MounjaroTirzepatide50$62,095
EliquisApixaban43$27,243
JanuviaSitagliptin Phosphate19$24,427
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,042
FarxigaDapagliflozin Propanediol14$10,311
EntrestoSacubitril/Valsartan13$8,779
LinzessLinaclotide15$8,104
Breo ElliptaFluticasone/Vilanterol12$4,707
SynthroidLevothyroxine Sodium33$2,768
Albuterol Sulfate HfaAlbuterol Sulfate53$1,480
Levothyroxine Sodium96$1,114
Sucralfate17$1,084
Celecoxib30$1,027
Famotidine55$965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$219$155,856133 claims
Lilly USA, LLCMounjaro$148$62,09550 claims
PfizerEliquis$73$27,24343 claims
GSKTrelegy Ellipta, Breo Ellipta$20$15,74929 claims
AbbVieLinzess, Synthroid$415$10,87248 claims
AstraZenecaFarxiga$102$10,31114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Vidalia

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →